Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study

BACKGROUND: Tuberculosis (TB) disease is a common opportunistic infection among people living with HIV (PLHIV). WHO recommends at least 6 months of isoniazid Preventive Therapy (IPT) to reduce the risk of active TB. It is important to monitor the six-month IPT completion since a suboptimal dose may...

Descripción completa

Detalles Bibliográficos
Autores principales: Robert, Masanja, Todd, Jim, Ngowi, Bernard J., Msuya, Sia E., Ramadhani, Angella, Sambu, Veryhel, Jerry, Isaya, Mujuni, Martin R., Mahande, Michael J., Ngocho, James S., Maokola, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147031/
https://www.ncbi.nlm.nih.gov/pubmed/32276618
http://dx.doi.org/10.1186/s12879-020-04997-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147031/
https://www.ncbi.nlm.nih.gov/pubmed/32276618
http://dx.doi.org/10.1186/s12879-020-04997-6

Ejemplares similares